 |
lenalidomide |
|---|---|
| Trade Name | Revlimid(R) |
| Orphan Indication | Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue |
| USA Market Approval | USA |
| USA Designation Date | 2015-04-29 00:00:00 |
| Sponsor | Celgene Corporation;400 Connell Drive, Suite 7000;Berkley Heights, NJ, 07922 |
